Changes in Mood, Depression and Suicidal Ideation after commencing Pregabalin for neuropathic pain

Loading...
Thumbnail Image
File version
Author(s)
Hall, T
Shah, S
Ng, B
Feberwee, HM
Dotchin, L
Vandermost, M
King, MA
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2014
Size

107543 bytes

File type(s)

application/pdf

Location
License
Abstract

Background Pregabalin is a treatment option for patients with persistent neuropathic pain. Its use has been associated with changes in mood and the development of depression and/or suicidal ideation. Objective Case presentations were reviewed of five patients reporting changes in mood, depression and suicidal ideation from the first 50 (approximately) patients commenced on pregabalin at the clinic. Discussion Although these patients had a history of depression, their mood had been stable before commencing pregabalin. Soon after commencement they reported changes in mood, and development of depression and/or suicidal ideation, which improved with dose reduction or cessation of pregabalin. Ultimately, all five patients ceased pregabalin treatment. Suicidal ideation is a recog-nised adverse effect of pregabalin. Patients should be warned of and monitored for deterioration in mood.

Journal Title

Australian Family Physician

Conference Title
Book Title
Edition
Volume

43

Issue

10

Thesis Type
Degree Program
School
DOI
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

© 2014 Australian Family Physician. Reproduced with permission. Permission to reproduce must be sought from the publisher, The Royal Australian College of General Practitioners.

Item Access Status
Note
Access the data
Related item(s)
Subject

Clinical sciences

Clinical pharmacology and therapeutics

Persistent link to this record
Citation
Collections